• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺气肿性肺大疱相关肺腺癌中程序性死亡配体1表达的高频率

High Frequency of Programmed Death-ligand 1 Expression in Emphysematous Bullae-associated Lung Adenocarcinomas.

作者信息

Toyokawa Gouji, Takada Kazuki, Okamoto Tatsuro, Kozuma Yuka, Matsubara Taichi, Haratake Naoki, Takamori Shinkichi, Akamine Takaki, Katsura Masakazu, Shoji Fumihiro, Oda Yoshinao, Maehara Yoshihiko

机构信息

Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan; Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

出版信息

Clin Lung Cancer. 2017 Sep;18(5):504-511.e1. doi: 10.1016/j.cllc.2016.11.011. Epub 2016 Dec 9.

DOI:10.1016/j.cllc.2016.11.011
PMID:28038981
Abstract

OBJECTIVE

Emphysematous bullae (EB) are known to be associated with a high incidence of lung cancer; however, the reason for this has yet to be elucidated. The objective of the present study was to clarify the prevalence of programmed death-ligand-1 (PD-L1) expression in EB-associated lung adenocarcinomas.

PATIENTS AND METHODS

A total of 369 patients with resected lung adenocarcinoma whose preoperative computed tomography findings were available for the examination of EB were analyzed for PD-L1 expression by immunohistochemistry and evaluated to determine the association between PD-L1 expression and EB-related adenocarcinomas.

RESULTS

Among 369 patients, EB and cancer adjoining EB (Ca-ADJ) were identified in 81 (22.0%) and 50 (13.6%) patients, respectively. EB and Ca-ADJ were significantly associated with male gender, a smoking habit, a decreased forced expiratory volume in 1 second, a relatively higher tumor grade, advanced T status and stage, the presence of pleural and vessel invasion, invasive pathologic subtypes, and wild-type epidermal growth factor receptor. Seventy patients (19.0%) were positive for PD-L1 expression, whereas the remaining 299 patients (81.0%) were negative. Thirty-six (44.4%) and 29 (58.0%) of 81 and 50 patients with EB and Ca-ADJ, respectively, were positive for PD-L1 expression, which was shown to be significant by the Fisher exact test (P < .001 and P < .001, respectively). Among the 81 lung adenocarcinomas with EB, Ca-ADJ was significantly associated with PD-L1 expression (P = .021). In a multivariate analysis, the presence of Ca-ADJ was found to be an independent predictor of PD-L1 expression.

CONCLUSIONS

EB-associated lung adenocarcinomas express PD-L1 protein more frequently than those without EB.

摘要

目的

已知肺大疱(EB)与肺癌的高发病率相关;然而,其原因尚未阐明。本研究的目的是明确程序性死亡配体1(PD-L1)在与EB相关的肺腺癌中的表达情况。

患者与方法

共有369例接受肺腺癌切除术的患者,其术前计算机断层扫描结果可用于EB检查,通过免疫组织化学分析PD-L1表达,并评估PD-L1表达与EB相关腺癌之间的关联。

结果

在369例患者中,分别有81例(22.0%)和50例(13.6%)患者被诊断为EB和癌旁EB(Ca-ADJ)。EB和Ca-ADJ与男性、吸烟习惯、一秒用力呼气量降低、肿瘤分级相对较高、T分期和阶段进展、胸膜和血管侵犯的存在、浸润性病理亚型以及野生型表皮生长因子受体显著相关。70例患者(19.0%)PD-L1表达呈阳性,其余299例患者(81.0%)为阴性。81例EB患者中有36例(44.4%)PD-L1表达呈阳性,50例Ca-ADJ患者中有29例(58.0%)呈阳性,Fisher精确检验显示差异有统计学意义(P分别<0.001和P<0.001)。在81例伴有EB的肺腺癌中,Ca-ADJ与PD-L1表达显著相关(P = 0.021)。多因素分析发现,Ca-ADJ的存在是PD-L1表达的独立预测因素。

结论

与EB相关的肺腺癌比无EB的肺腺癌更频繁地表达PD-L1蛋白。

相似文献

1
High Frequency of Programmed Death-ligand 1 Expression in Emphysematous Bullae-associated Lung Adenocarcinomas.肺气肿性肺大疱相关肺腺癌中程序性死亡配体1表达的高频率
Clin Lung Cancer. 2017 Sep;18(5):504-511.e1. doi: 10.1016/j.cllc.2016.11.011. Epub 2016 Dec 9.
2
Invasive features of small-sized lung adenocarcinoma adjoining emphysematous bullae.毗邻气肿性大疱的小尺寸肺腺癌的侵袭特征。
Eur J Cardiothorac Surg. 2018 Feb 1;53(2):372-378. doi: 10.1093/ejcts/ezx295.
3
Relevance Between Programmed Death Ligand 1 and Radiologic Invasiveness in Pathologic Stage I Lung Adenocarcinoma.程序性死亡配体1与病理I期肺腺癌放射学侵袭性之间的相关性
Ann Thorac Surg. 2017 Jun;103(6):1750-1757. doi: 10.1016/j.athoracsur.2016.12.025. Epub 2017 Mar 24.
4
A Comprehensive Analysis of Programmed Cell Death Ligand-1 Expression With the Clone SP142 Antibody in Non-Small-Cell Lung Cancer Patients.使用克隆SP142抗体对非小细胞肺癌患者程序性细胞死亡配体-1表达的综合分析
Clin Lung Cancer. 2017 Sep;18(5):572-582.e1. doi: 10.1016/j.cllc.2017.02.004. Epub 2017 Mar 2.
5
Programmed Death Ligand-1 (PD-L1) Expression in Either Tumor Cells or Tumor-Infiltrating Immune Cells Correlates With Solid and High-Grade Lung Adenocarcinomas.程序性死亡配体1(PD-L1)在肿瘤细胞或肿瘤浸润免疫细胞中的表达与实性和高级别肺腺癌相关。
Arch Pathol Lab Med. 2017 Nov;141(11):1529-1532. doi: 10.5858/arpa.2017-0028-OA. Epub 2017 Aug 22.
6
Clinical Significance of PD-L1 Protein Expression in Surgically Resected Primary Lung Adenocarcinoma.手术切除原发性肺腺癌中 PD-L1 蛋白表达的临床意义。
J Thorac Oncol. 2016 Nov;11(11):1879-1890. doi: 10.1016/j.jtho.2016.06.006. Epub 2016 Jun 23.
7
The Association Between Imaging Features of TSCT and the Expression of PD-L1 in Patients With Surgical Resection of Lung Adenocarcinoma.肺腺癌手术切除患者 TSCT 的影像学特征与 PD-L1 表达的相关性研究。
Clin Lung Cancer. 2019 Mar;20(2):e195-e207. doi: 10.1016/j.cllc.2018.10.012. Epub 2018 Nov 14.
8
Clinicopathological and prognostic significance of programmed cell death ligand-1 expression in lung adenocarcinoma and its relationship with p53 status.程序性细胞死亡配体-1在肺腺癌中的表达的临床病理及预后意义及其与p53状态的关系
Lung Cancer. 2016 Jul;97:73-80. doi: 10.1016/j.lungcan.2016.05.001. Epub 2016 May 3.
9
Programmed Cell Death Ligand (PD-L1) Expression in Stage II and III Lung Adenocarcinomas and Nodal Metastases.程序性细胞死亡配体(PD-L1)在 II 期和 III 期肺腺癌及淋巴结转移中的表达。
J Thorac Oncol. 2017 Mar;12(3):458-466. doi: 10.1016/j.jtho.2016.10.015. Epub 2016 Nov 2.
10
Programmed cell death-ligand 1 expression in surgically resected stage I pulmonary adenocarcinoma and its correlation with driver mutations and clinical outcomes.手术切除的 I 期肺腺癌中程序性细胞死亡配体 1 的表达及其与驱动基因突变和临床结局的关系。
Eur J Cancer. 2014 May;50(7):1361-9. doi: 10.1016/j.ejca.2014.01.018. Epub 2014 Feb 15.

引用本文的文献

1
Lung Cancer Associated with Cystic Airspaces: Current Insights into Diagnosis, Pathophysiology, and Treatment Strategies.与囊性气腔相关的肺癌:诊断、病理生理学及治疗策略的当前见解
Cancers (Basel). 2024 Nov 24;16(23):3930. doi: 10.3390/cancers16233930.
2
Efficacy and safety of pembrolizumab as first-line treatment for advanced non-small cell lung cancer complicated with chronic obstructive pulmonary disease: protocol for a prospective, single-arm, single-center, phase II clinical trial.帕博利珠单抗作为一线治疗方案用于晚期非小细胞肺癌合并慢性阻塞性肺疾病的疗效和安全性:一项前瞻性、单臂、单中心、II期临床试验方案
Front Oncol. 2024 Mar 7;14:1179232. doi: 10.3389/fonc.2024.1179232. eCollection 2024.
3
Impact of chronic obstructive pulmonary disease on the efficacy and safety of neoadjuvant immune checkpoint inhibitors combined with chemotherapy for resectable non-small cell lung cancer: a retrospective cohort study.
慢性阻塞性肺疾病对可切除性非小细胞肺癌新辅助免疫检查点抑制剂联合化疗疗效和安全性的影响:一项回顾性队列研究。
BMC Cancer. 2024 Jan 30;24(1):153. doi: 10.1186/s12885-024-11902-w.
4
ZNF143 Expression is Associated with COPD and Tumor Microenvironment in Non-Small Cell Lung Cancer.ZNF143 表达与非小细胞肺癌中的 COPD 和肿瘤微环境相关。
Int J Chron Obstruct Pulmon Dis. 2022 Apr 2;17:685-700. doi: 10.2147/COPD.S352392. eCollection 2022.
5
Coexistence of Emphysema With Non-small-cell Lung Cancer Predicts the Therapeutic Efficacy of Immune Checkpoint Inhibitors.肺气肿与非小细胞肺癌共存可预测免疫检查点抑制剂的治疗效果。
In Vivo. 2021 Jan-Feb;35(1):467-474. doi: 10.21873/invivo.12280.
6
Prognostic impact of primary cancer adjoining emphysematous bullae in non-small cell lung cancer patients treated with immune checkpoint inhibitors.原发性癌毗邻气肿性大疱对接受免疫检查点抑制剂治疗的非小细胞肺癌患者预后的影响。
Cancer Immunol Immunother. 2021 Jun;70(6):1745-1753. doi: 10.1007/s00262-020-02783-6. Epub 2021 Jan 3.
7
PD-L1, FGFR1, PIK3CA, PTEN, and p16 expression in pulmonary emphysema and chronic obstructive pulmonary disease with resected lung squamous cell carcinoma.肺鳞状细胞癌切除术后肺气肿和慢性阻塞性肺疾病中 PD-L1、FGFR1、PIK3CA、PTEN 和 p16 的表达。
BMC Pulm Med. 2019 Sep 3;19(1):169. doi: 10.1186/s12890-019-0913-8.
8
Diagnostic and clinical features of lung cancer associated with cystic airspaces.与肺气囊相关的肺癌的诊断及临床特征
J Thorac Dis. 2019 Mar;11(3):987-1004. doi: 10.21037/jtd.2019.02.91.
9
Radiological Features of Programmed Cell Death-Ligand 2-positive Lung Adenocarcinoma: A Single-institution Retrospective Study.程序性细胞死亡配体2阳性肺腺癌的影像学特征:一项单机构回顾性研究
In Vivo. 2018 Nov-Dec;32(6):1541-1550. doi: 10.21873/invivo.11412.
10
Impact of the favorable prognosis of patients with lung cancer adjoining bullae.肺癌合并肺大疱患者预后良好的影响。
J Thorac Dis. 2018 Jun;10(6):3289-3297. doi: 10.21037/jtd.2018.05.125.